Endothelial function and hemostasis

Zeitschrift fur Kardiologie

Volumn 89, Issue 3, 2000, Pages 160-167

  Becker, B F ^a   Heindl, B ^a   Kupatt, C ^a   Zahler, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adhesion molecule; CD40; Coagulation; Granulocyte; Inflammation; Leukocyte; Platelet; PMN; Thr ombin; Tissue factor

Indexed keywords

ADENOSINE; ANTITHROMBIN III; CD40 ANTIGEN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLUTATHIONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; SUPEROXIDE DISMUTASE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOMODULIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BLOOD CLOTTING; CONFERENCE PAPER; FIBRINOLYSIS; GRANULOCYTE; HEMOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0034031828     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007320     Document Type: Conference Paper

References (54)

1. 1. Bates S, Weitz JI (1999) Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin. Cardiovasc Res 41:418-432
2. 2. Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615-631
3. 3. Becker BF, Kupatt C, Raschke P, Zahler S (1996) Microcirculatory disturbances due to activated leukocytes in ischemic and reperfusion injury. In: Kamada T, Shiga T, McCuskey RS (eds) Tissue Perfusion and Organ Function: Ischemia/Reperfusion Injury. Elsevier Science Publishers, Amsterdam, pp 97-107
4. 4. Becker BF, Leipert B, Raschke P, Gerlach E, Permanetter B (1991) Formation, release and scavenger function of uric acid derived from adenine nucleotides in heart and lung. In: Imai S, Nakazawa M (eds) Role of Adenosine and Adenine Nucleotides in the Biological System. Elsevier Science Publishers, Amsterdam, pp 321-336
5. 5. Becker BF, Massoudy P, Permanetter B, Raschke P, Zahler S (1993) Mögliche Bedeutung von Sauerstoffradikalen für den Reperfusionsschaden. Z Kardiol 82 (Suppl 5):49-58
6. 6. Becker BF, Seligmann C, Beblo S, Zahler S (1995) Physiologie und Pathophysiologie der Hämostase. In: Baumann G (ed) Antikoagulantien und Thrombozytenag-gregationshemmer bei kardialen Erkrankungen: Nutzen und Risiko. Klaus Pia Verlagsgesellschaft, Nürnberg, pp 8-17
7. 7. Becker BF, Zahler S, Seligmann C, Kupatt C, Habazettl H (1996) Interaktion von Adenosin mit Leukozyten und Thrombozyten. Z Kardiol 85 (Suppl 6):161-170
8. 8. Bertina RM, Reitsma PH, Rosendaal FR, Vandenboucke JP (1997) Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 74:449-453
9. 9. Boehme MWJ, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP (1996) Release of thrombomodulin from endothelial cells by concerted action of TNFα and neutrophils: in vivo and in vitro studies. Immunol 87:134-140
10. 10. Bombeli T, Mueller M, Haeberli A (1997) Anticoagulant properties of the vascular endothelium. Thromb Haemost 77:408-423
11. 11. Buckley BH, Roberts WC (1974) Steroid therapy during acute myocardial infarction: a cause of delayed healing and ventricular aneurysm. Am J Med 56: 244-250
12. 12. Busse R, Fleming I (1998) Pulsatile stretch and shear stress: physical stimuli determining the production of endotheiium-derived relaxing factors. J. Vasc Res 35:73-84
13. 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 271:29034-29042
14. 14. Cameron D (1996) Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. J Cardiovasc Pharm 27(Suppl 1):S1-S5
15. 15. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023-11027
16. 16. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G (1992) Neutrophil adherence to endotheiium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148:2201-2206
17. 17. Eguchi H, Ikeda H, Murohara T, Yasukawa H, Haramaki N, Sakisaka S, Imaizumi T (1999) Endothelial injuries of coronary arteries distal to thrombotic sites. Circ Res 84:525-535
18. 18. Esmon CT, Schwarz HP (1995) An update on clinical and basic aspects of the protein C anticoagulant pathway. Trends Cardiovasc Med 5:141-148
19. 19. Gerlach E, Becker BF (1993) Interaktion von Blut und Gefäßwand: Hämostaseologische Aspekte. Z Kardiol 82 (Suppl 5):13-21
20. 20. Geriach E, Becker BF, Nees S (1987) Formation of adenosine by vascular endothelium: a homeostatic and antithrombogenic mechanism? In: Gerlach E, Becker BF (eds) Topics and Perspectives in Adenosine Research. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 309-320
21. 21. Gerlach E, Nees S, Becker BF (1985) The vascular endothelium: a survey of some newly evolving biochemical and physiological features. Basic Res Cardiol 80:459-474
22. 22. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96:2311-2315
23. 23. Heindl B, Conzen P, Becker BF (1999) The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 94:102-111
24. 24. Heindl B, Zahler S, Welsch U, Becker BF (1998) Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts. Cardiovasc Res 38: 383-394
25. 25. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Mùller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
26. 26. Hooper WC, Phillips DJ, Renshaw MA, Evatt BL, Benson JM (1998) The upregulation of IL-6 and IL-8 in human endothelial cells by activated protein C. J Immunol 161:2567-2573
27. 27. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L (1998) Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 160: 5130-5135
28. 28. Kong DF, Califf RM, Miller DP, Moliterno DJ, White HD, Harrington RA, Tcheng JE, Lincoff AM, Hasselblad V, Topol EJ (1998) Clinical outcome of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circ 98:2829-2835
29. 29. Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA, Becker BF (1999) Tumor necrosis factor-a contributes to ischemia and reperfusion-induced endothelial activation in isolated hearts. Circ Res 84: 392-400
30. 30. Kupatt C, Zahler S, Seligmann C, Massoudy P, Becker BF, Gerlach E (1996) Nitric oxide mitigates leukocyte adhesion and vascular permeability changes after myocardial ischemia. J Mol Cell Cardiol 28:643-654
31. 31. Lindahl AK (1995) Tissue factor pathway inhibitor in health and disease. Trends Cardiovasc med 5:167-171
32. 32. Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA (1991) Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 115:223-234
33. 33. Madan M, Berkowitz SD, Tcheng JE (1998) Glycoprotein IIb/IIIa integrin blockade. Circ 98:2629-2635
34. 34. Massoudy P, Becker BF, Gerlach E (1995) Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig heart. J Cardiovasc Pharmacol 25:440-447
35. 35. Massoudy P, Zahler S, Freyholdt T, Henze R, Barankay A, Becker BF, Braun SL, Meisner H (2000) Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: Reduction of cardiac proinflammatory substances. J Thorac Cardiovasc Surg 119:566-574
36. 36. Newman PJ (1994) The role of PE-CAM-1 in vascular biology. Ann NY Acad Sci 714:165-174
37. 37. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schömig A (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circ 92:748-755
38. 38. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schömig A (1997) Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 17:3399-3405
39. 39. Nolte D, Lorenzen A, Lehr H-A, Zimmer F-J, Klotz K-N, Messmer K (1992) Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 346:234-237
40. 40. Papapetropoulos A, Piccardoni P, Cirino G, Bucci M, Sorrentino R, Cicala C, Johnson K, Zachariou V, Sessa WC, Altieri DC (1998) Hypotension and inflammatory cytokine expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA 95:4738-4742
41. 41. Randolph GJ, Luther T, Albrecht S, Magdolen V, Muller WA (1998) Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 92:4167-4177
42. 42. Raschke P, Becker BF (1995) Adenosine and PAF-dependent mechanisms lead to myocardial reperfusion injury by polymorphonuclear neutrophils after brief ischaemia. Cadiovasc Res 29:569-576
43. 43. Resnick N, Gimbrone Jr. MA (1995) Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9:874-882
44. 44. Ruggeri ZM (1994) Glycoprotein Ib and von Willebrand factor in the process of thrombus formation. Ann N Y Acad Sci 714:200-210
45. 45. Ruggeri ZM, Ware J (1993) von Willebrand factor. FASEB J 7:308-316
46. 46. Seligmann C, Kupatt C, Becker BF, Zahler S, Beblo S (1998) Adenosine endogenously released during early reperfusion mitigates postischemic myocardial dysfunction by inhibiting platelet adhesion. J Cardiovasc Pharmacol 32: 156-163
47. 47. Sixma JJ, de Groot PG (1994) Regulation of platelet adhesion to the vessel wall. Ann N Y Acad Sci 714:190-199
48. 48. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT (1996) In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin - labeled factors VIIa and X. Lab Invest 75:451-460
49. 49. Venturini CM, Kaplan JE (1992) Thrombin induces platelet adhesion to endothelial cells. Seminars Thromb Hemostasis 18:275-283
50. 50. Weiss HJ (1995) Flow-related platelet deposition on subendothelium. Thromb Haemost 74:117-122
51. 51. Zahler S, Becker BF, Raschke P, Gerlach E (1994) Stimulation of endothelial adenosine A1-receptors enhances adhesion of neutrophils in the intact guinea pig coronary system. Cardiovasc Res 28:1366-1372
52. 52. Zahler S, Kupatt C, Möbert J, Becker BF, Gerlach E (1997) Effects of ACE-inhibition on redox status and expression of P-selectin of endothelial cells subjected to oxidative stress. J Mol Cell Cardiol 29:2953-2960
53. 53. Zahler S, Massoudy P, Hartl H, Hähnel C, Meisner H, Becker BF (1999) Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 41:722-730
54. 54. Zeiher AM, Schächinger V, Weitzel SH, Wollschläger H, Just H (1991) Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circ 83:1519-1525